ZTSZoetis Inc.

$53B

FY 2012 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.3B+2.4% YoY

Gross Profit

$2.7B62.7% margin

Operating Income

$854M19.7% margin

Net Income

$436M10.1% margin

EPS (Diluted)

$0.87

Cash Flow

Operating Cash Flow

$454M

Free Cash Flow

$328M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$6.3B

Total Liabilities

$2.2B

Stockholders' Equity

$4.0B

Cash & Equivalents

$317M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.3B	$4.2B	+2.4%
Gross Profit	$2.7B	$2.5B	+7.1%
Operating Income	$854M	$684M	+24.9%
Net Income	$436M	$245M	+78.0%

ZTS FY 2012 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena